Clinical risk management in the 99m-Tc-MIBI quality control procedure in nuclear medicine. Case study.
giallo
PDF

How to Cite

Rossetti , F., Rizzo , V., De Francesco , L., Spirito , M., Farese , R., Pastore , S., & Frasca , C. (2022). Clinical risk management in the 99m-Tc-MIBI quality control procedure in nuclear medicine. Case study. Journal of Advanced Health Care, 4(6). https://doi.org/10.36017/jahc202246194

Abstract

The work is based on daily work protocols used within a Nuclear Medicine Operating Unit in which all modern
radiopharmaceuticals are used and quality control procedures are applied to the latter. It is essential to underline,
also with the production of this article, the importance of quality controls and the collaboration of the various
figures in the field in order to avoid inappropriate injection of radiopharmaceuticals and to guarantee the safety
and appropriateness of the procedures with an effective clinical risk management in contrast and prevent technical
errors and penalizing the injection and acquisition of diagnostic tests, sometimes urgent, and indispensable for the
diagnosis of even delicate pathologies

https://doi.org/10.36017/jahc202246194
PDF
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Copyright (c) 2022 Journal of Advanced Health Care